Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

被引：0
作者：
A. M. Peiró
M. Farré
P. N. Roset
M. Carbó
M. Pujadas
M. Torrens
J. Camí
R. de la Torre
机构：
[1] IMIM-Hospital del Mar Medical Research Institute,Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme
[2] Universitat Autònoma de Barcelona (UDIMAS-UAB),CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03)
[3] Universitat Pompeu Fabra (CEXS-UPF),undefined
[4] Addiction Unit - INAD,undefined
[5] Doctor Aiguader 88,undefined
[6] CIBEROBN,undefined
来源：
Psychopharmacology | 2013年 / 225卷
关键词：
MDMA; Ecstasy; Repeated dose; Humans; Metabolic inhibition; Pharmacologic effects; Pharmacokinetics; CYP2D6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 893
页数：10
相关论文
共 50 条
[21]   Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users [J].
Parrott, A. C. ;
Milani, R. M. ;
Gouzoulis-Mayfrank, E. ;
Daumann, J. .
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) :959-968
[22]   Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons [J].
Goodwin, Amy K. ;
Mueller, Melanie ;
Shell, Courtney D. ;
Ricaurte, George A. ;
Ator, Nancy A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (03) :342-353
[23]   Functional consequences of repeated (±)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys [J].
Taffe, MA ;
Weed, MR ;
Davis, S ;
Huitrón-Resendiz, S ;
Schroeder, R ;
Parsons, LH ;
Henriksen, SJ ;
Gold, LH .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (03) :230-239
[24]   Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse [J].
Dinis-Oliveira, Ricardo Jorge ;
Caldas, Ines ;
Carvalho, Felix ;
Magalhaes, Teresa .
CLINICAL TOXICOLOGY, 2010, 48 (08) :863-864
[25]   Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") [J].
Wunderli, Michael D. ;
Vonmoos, Matthias ;
Treichler, Lorena ;
Zeller, Carmen ;
Dziobek, Isabel ;
Kraemer, Thomas ;
Baumgartner, Markus R. ;
Seifritz, Erich ;
Quednow, Boris B. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (04) :333-344
[26]   Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users [J].
McCann, Una D. ;
Edwards, Robert R. ;
Smith, Michael T. ;
Kelley, Kristen ;
Wilson, Michael ;
Sgambati, Francis ;
Ricaurte, George .
PSYCHOPHARMACOLOGY, 2011, 217 (04) :475-484
[27]   Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys [J].
Michael A Taffe ;
Michael R Weed ;
Sophia Davis ;
Salvador Huitrón-Resendiz ;
Richard Schroeder ;
Loren H Parsons ;
Steven J Henriksen ;
Lisa H Gold .
Neuropsychopharmacology, 2001, 24 :230-239
[28]   The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences [J].
Wyeth, Richard P. ;
Mills, Edward M. ;
Ullman, Alison ;
Kenaston, M. Alexander ;
Burwell, Johanna ;
Sprague, Jon E. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) :33-38
[29]   Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users [J].
Una D. McCann ;
Robert R. Edwards ;
Michael T. Smith ;
Kristen Kelley ;
Michael Wilson ;
Francis Sgambati ;
George Ricaurte .
Psychopharmacology, 2011, 217 :475-484
[30]   Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence [J].
Dafters, RI ;
Duffy, F ;
O'Donnell, PJ ;
Bouquet, C .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :82-90
12345